Solutions For Cell And Gene Therapy Manufacturing

Cell and gene therapies — particularly activated T-cell therapies like CAR-T and TCR-T — are revolutionizing the treatment of serious diseases, offering transformative outcomes where traditional therapies have fallen short. With recent CAR-T approvals and a surge in clinical trials, the path from discovery to clinical development and commercial manufacturing is rapidly accelerating.

As a trusted partner to the world’s top 20 biopharmaceutical companies, Avantor® brings deep expertise and a comprehensive portfolio designed to address the unique challenges of this rapidly evolving field. Our high-purity production chemicals, sterile fluid transfer systems, cell culture components, and excipient technologies are engineered to support the scalability and manufacturability of viral vector production and cell and gene therapy workflows. With our support, you can bring innovative, life-saving therapies to market safely, efficiently, and at scale.